The Latest in CLL

Idelalisib efficacy remains rock steady in relapsed CLL

June 23, 2014

CLL

Ibrutinib holds CLL at bay in majority of patients at 30 months

June 17, 2014

CLL

VIDEO: Ibrutinib boosts survival of relapsed/refractory CLL

June 2, 2014

CLL

Drugs approved in 2013

May 21, 2014

FDA approves ofatumumab for chronic lymphocytic leukemia

April 17, 2014

CLL

Persistent lymphocytosis with ibrutinib does not indicate early relapse

March 28, 2014

CLL

Idelalisib and rituximab extends survival in CLL patients

January 22, 2014

CLL

ONO-4059 makes waves in heavily pretreated CLL

January 10, 2014

FDA provides steps to obtain ponatinib following suspension

November 6, 2013

CLL